HEADER HORMONE/GROWTH FACTOR 06-NOV-03 1RDT
TITLE CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHA LIGAND
TITLE 2 BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: RETINOIC ACID RECEPTOR RXR-ALPHA;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: LIGAND BINDING DOAMIN;
COMPND 5 SYNONYM: RXRALPHA;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: LXXLL MOTIF COACTIVATOR;
COMPND 9 CHAIN: B;
COMPND 10 FRAGMENT: LXXLL PEPTIDE;
COMPND 11 ENGINEERED: YES;
COMPND 12 MOL_ID: 3;
COMPND 13 MOLECULE: PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
COMPND 14 CHAIN: D;
COMPND 15 FRAGMENT: LIGAND BINDING DOAMIN;
COMPND 16 SYNONYM: PPAR-GAMMA;
COMPND 17 ENGINEERED: YES;
COMPND 18 MOL_ID: 4;
COMPND 19 MOLECULE: LXXLL MOTIF COACTIVATOR;
COMPND 20 CHAIN: E;
COMPND 21 FRAGMENT: LXXLL PEPTIDE;
COMPND 22 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: RXRA, NR2B1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PACYC184;
SOURCE 11 MOL_ID: 2;
SOURCE 12 SYNTHETIC: YES;
SOURCE 13 MOL_ID: 3;
SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 15 ORGANISM_COMMON: HUMAN;
SOURCE 16 ORGANISM_TAXID: 9606;
SOURCE 17 GENE: PPARG, NR1C3;
SOURCE 18 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 19 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 20 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PRSET;
SOURCE 23 MOL_ID: 4;
SOURCE 24 SYNTHETIC: YES
KEYWDS HORMONE, RECEPTOR, POLYMORPHISM, HORMONE-GROWTH FACTOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR C.D.HAFFNER,J.M.LENHARD,A.B.MILLER,D.L.MCDOUGALD,K.DWORNIK,
AUTHOR 2 O.R.ITTOOP,R.T.GAMPE JR.,H.E.XU,S.BLANCHARD,V.G.MONTANA
REVDAT 3 23-AUG-23 1RDT 1 REMARK SEQADV HETSYN
REVDAT 2 24-FEB-09 1RDT 1 VERSN
REVDAT 1 09-NOV-04 1RDT 0
JRNL AUTH C.D.HAFFNER,J.M.LENHARD,A.B.MILLER,D.L.MCDOUGALD,K.DWORNIK,
JRNL AUTH 2 O.R.ITTOOP,R.T.GAMPE JR.,H.E.XU,S.BLANCHARD,V.G.MONTANA,
JRNL AUTH 3 T.G.CONSLER,R.K.BLEDSOE,A.AYSCUE,D.CROOM
JRNL TITL STRUCTURE-BASED DESIGN OF POTENT RETINOID X RECEPTOR ALPHA
JRNL TITL 2 AGONISTS.
JRNL REF J.MED.CHEM. V. 47 2010 2004
JRNL REFN ISSN 0022-2623
JRNL PMID 15056000
JRNL DOI 10.1021/JM030565G
REMARK 2
REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX 2000
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK 3 : YIP,DZAKULA)
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 330222.
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.1
REMARK 3 NUMBER OF REFLECTIONS : 21429
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.221
REMARK 3 R VALUE (WORKING SET) : 0.221
REMARK 3 FREE R VALUE : 0.259
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900
REMARK 3 FREE R VALUE TEST SET COUNT : 2121
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.060
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.30
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3032
REMARK 3 BIN R VALUE (WORKING SET) : 0.2350
REMARK 3 BIN FREE R VALUE : 0.2830
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.60
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 359
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3753
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 69
REMARK 3 SOLVENT ATOMS : 205
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 34.50
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.30
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27
REMARK 3 ESD FROM SIGMAA (A) : 0.16
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.23
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.005
REMARK 3 BOND ANGLES (DEGREES) : 1.300
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.70
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.690
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1RDT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-03.
REMARK 100 THE DEPOSITION ID IS D_1000020670.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 08-AUG-99
REMARK 200 TEMPERATURE (KELVIN) : 93.0
REMARK 200 PH : 7.50
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25137
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : 0.07100
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 36.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : 86.6
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.42200
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: CNX 2000
REMARK 200 STARTING MODEL: PDB ENTRY 1FM9
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 44.43
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 17% PEG 4K, 200MM NASCN, 8% ETHYLENE
REMARK 280 GLYCOL, 8% GLYCEROL, PH 7.5, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 295K, PH 7.50
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.84500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 105.85000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.29000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 105.85000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.84500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.29000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, E
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 221
REMARK 465 LYS A 222
REMARK 465 LYS A 223
REMARK 465 GLY A 224
REMARK 465 SER A 225
REMARK 465 ALA A 226
REMARK 465 ASN A 227
REMARK 465 LYS A 245
REMARK 465 THR A 246
REMARK 465 GLU A 247
REMARK 465 THR A 248
REMARK 465 TYR A 249
REMARK 465 VAL A 250
REMARK 465 GLU A 251
REMARK 465 ALA A 252
REMARK 465 ASN A 253
REMARK 465 MET A 254
REMARK 465 GLY A 255
REMARK 465 LEU A 256
REMARK 465 ASN A 257
REMARK 465 PRO A 258
REMARK 465 SER A 259
REMARK 465 SER A 260
REMARK 465 PRO A 261
REMARK 465 ASN A 262
REMARK 465 ALA A 457
REMARK 465 PRO A 458
REMARK 465 HIS A 459
REMARK 465 GLN A 460
REMARK 465 MET A 461
REMARK 465 THR A 462
REMARK 465 CYS B 676
REMARK 465 PRO B 677
REMARK 465 SER B 678
REMARK 465 SER B 679
REMARK 465 HIS B 680
REMARK 465 SER B 681
REMARK 465 SER B 682
REMARK 465 LEU B 683
REMARK 465 THR B 684
REMARK 465 GLU B 685
REMARK 465 ARG B 686
REMARK 465 GLU B 696
REMARK 465 GLY B 697
REMARK 465 SER B 698
REMARK 465 PRO B 699
REMARK 465 SER B 700
REMARK 465 MET D 194
REMARK 465 LYS D 195
REMARK 465 LYS D 196
REMARK 465 GLY D 197
REMARK 465 HIS D 198
REMARK 465 HIS D 199
REMARK 465 HIS D 200
REMARK 465 HIS D 201
REMARK 465 HIS D 202
REMARK 465 HIS D 203
REMARK 465 GLY D 204
REMARK 465 ARG D 205
REMARK 465 MET D 257
REMARK 465 GLY D 258
REMARK 465 GLU D 259
REMARK 465 ASP D 260
REMARK 465 LYS D 261
REMARK 465 ILE D 262
REMARK 465 LYS D 263
REMARK 465 PHE D 264
REMARK 465 LYS D 265
REMARK 465 HIS D 266
REMARK 465 ILE D 267
REMARK 465 THR D 268
REMARK 465 PRO D 269
REMARK 465 LEU D 270
REMARK 465 GLN D 271
REMARK 465 GLU D 272
REMARK 465 GLN D 273
REMARK 465 SER D 274
REMARK 465 LYS D 275
REMARK 465 ASN E 57
REMARK 465 LEU E 58
REMARK 465 VAL E 59
REMARK 465 PRO E 60
REMARK 465 ASP E 61
REMARK 465 ALA E 62
REMARK 465 ALA E 63
REMARK 465 SER E 64
REMARK 465 LYS E 65
REMARK 465 HIS E 66
REMARK 465 ARG E 74
REMARK 465 GLY E 75
REMARK 465 GLY E 76
REMARK 465 SER E 77
REMARK 465 GLY E 78
REMARK 465 SER E 79
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ASP A 263 CB CG OD1 OD2
REMARK 470 LEU A 330 CG CD1 CD2
REMARK 470 ASP A 444 CB CG OD1 OD2
REMARK 470 THR A 445 CB OG1 CG2
REMARK 470 PRO A 446 CB CG CD
REMARK 470 ILE A 447 CB CG1 CG2 CD1
REMARK 470 ASP A 448 CB CG OD1 OD2
REMARK 470 LYS B 688 CG CD CE NZ
REMARK 470 TYR D 250 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 470 MET D 252 CB CG SD CE
REMARK 470 ASN D 253 CB CG OD1 ND2
REMARK 470 ILE D 279 CG1 CG2 CD1
REMARK 470 LYS D 354 CG CD CE NZ
REMARK 470 THR D 461 CB OG1 CG2
REMARK 470 MET D 463 CG SD CE
REMARK 470 LYS E 67 CG CD CE NZ
REMARK 470 GLN E 68 CG CD OE1 NE2
REMARK 470 LEU E 69 CB CG CD1 CD2
REMARK 470 SER E 70 OG
REMARK 470 GLU E 71 CG CD OE1 OE2
REMARK 470 LEU E 72 CG CD1 CD2
REMARK 470 LEU E 73 CG CD1 CD2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 CG GLU A 233 O HOH A 103 1.65
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 CD1 LEU A 240 NE ARG B 692 3645 1.66
REMARK 500 CD1 LEU A 240 CD ARG B 692 3645 1.76
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 229 -37.77 83.80
REMARK 500 MET A 230 63.74 -152.79
REMARK 500 HIS A 288 -13.73 79.09
REMARK 500 LYS A 321 -92.45 -57.30
REMARK 500 ASP A 322 68.45 -117.86
REMARK 500 HIS A 338 44.54 -79.75
REMARK 500 SER A 339 -18.41 -152.72
REMARK 500 LEU A 353 -70.27 -124.23
REMARK 500 ASN A 385 77.99 -150.51
REMARK 500 LEU A 441 52.06 -69.22
REMARK 500 ILE A 442 -27.13 -161.92
REMARK 500 ASP A 444 41.94 87.08
REMARK 500 THR A 445 53.93 90.19
REMARK 500 PRO A 446 -173.94 -48.23
REMARK 500 ASP D 243 -49.63 -153.29
REMARK 500 LYS D 244 115.62 169.19
REMARK 500 SER D 342 71.39 52.02
REMARK 500 GLU D 343 14.41 56.71
REMARK 500 LYS D 358 -146.87 28.85
REMARK 500 GLN D 430 28.60 46.34
REMARK 500 ASP D 462 56.20 -100.58
REMARK 500 MET D 463 -79.14 -48.00
REMARK 500 SER D 464 109.78 56.65
REMARK 500 LEU D 476 -119.00 -90.08
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L79 A 463
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 570 D 478
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1FM9 RELATED DB: PDB
REMARK 900 THE 2.1A CRYSTAL STRUCTURE OF 9CIS RETINOIC ACID AND GI262570
REMARK 900 RESPECTIVELY BOUND TO THE RXRALPHA / PPARGAMMA HETERODIMER
REMARK 900 COACTIVATED WITH SRC1(2) PEPTIDES
REMARK 900 RELATED ID: 1FM6 RELATED DB: PDB
REMARK 900 THE 2.1A CRYSTAL STRUCTURE OF 9CIS RETINOIC ACID AND ROSIGLITAZONE
REMARK 900 RESPECTIVELY BOUND TO THE RXRALPHA / PPARGAMMA HETERODIMER
REMARK 900 COACTIVATED WITH SRC1(2) PEPTIDES
DBREF 1RDT A 225 462 UNP P19793 RXRA_HUMAN 225 462
DBREF 1RDT D 207 477 UNP P37231 PPAT_HUMAN 235 505
DBREF 1RDT B 676 700 PDB 1RDT 1RDT 676 700
DBREF 1RDT E 57 79 PDB 1RDT 1RDT 57 79
SEQADV 1RDT MET A 221 UNP P19793 CLONING ARTIFACT
SEQADV 1RDT LYS A 222 UNP P19793 CLONING ARTIFACT
SEQADV 1RDT LYS A 223 UNP P19793 CLONING ARTIFACT
SEQADV 1RDT GLY A 224 UNP P19793 CLONING ARTIFACT
SEQADV 1RDT MET D 194 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT LYS D 195 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT LYS D 196 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT GLY D 197 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT HIS D 198 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT HIS D 199 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT HIS D 200 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT HIS D 201 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT HIS D 202 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT HIS D 203 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT GLY D 204 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT ARG D 205 UNP P37231 CLONING ARTIFACT
SEQADV 1RDT ALA D 206 UNP P37231 CLONING ARTIFACT
SEQRES 1 A 242 MET LYS LYS GLY SER ALA ASN GLU ASP MET PRO VAL GLU
SEQRES 2 A 242 ARG ILE LEU GLU ALA GLU LEU ALA VAL GLU PRO LYS THR
SEQRES 3 A 242 GLU THR TYR VAL GLU ALA ASN MET GLY LEU ASN PRO SER
SEQRES 4 A 242 SER PRO ASN ASP PRO VAL THR ASN ILE CYS GLN ALA ALA
SEQRES 5 A 242 ASP LYS GLN LEU PHE THR LEU VAL GLU TRP ALA LYS ARG
SEQRES 6 A 242 ILE PRO HIS PHE SER GLU LEU PRO LEU ASP ASP GLN VAL
SEQRES 7 A 242 ILE LEU LEU ARG ALA GLY TRP ASN GLU LEU LEU ILE ALA
SEQRES 8 A 242 SER PHE SER HIS ARG SER ILE ALA VAL LYS ASP GLY ILE
SEQRES 9 A 242 LEU LEU ALA THR GLY LEU HIS VAL HIS ARG ASN SER ALA
SEQRES 10 A 242 HIS SER ALA GLY VAL GLY ALA ILE PHE ASP ARG VAL LEU
SEQRES 11 A 242 THR GLU LEU VAL SER LYS MET ARG ASP MET GLN MET ASP
SEQRES 12 A 242 LYS THR GLU LEU GLY CYS LEU ARG ALA ILE VAL LEU PHE
SEQRES 13 A 242 ASN PRO ASP SER LYS GLY LEU SER ASN PRO ALA GLU VAL
SEQRES 14 A 242 GLU ALA LEU ARG GLU LYS VAL TYR ALA SER LEU GLU ALA
SEQRES 15 A 242 TYR CYS LYS HIS LYS TYR PRO GLU GLN PRO GLY ARG PHE
SEQRES 16 A 242 ALA LYS LEU LEU LEU ARG LEU PRO ALA LEU ARG SER ILE
SEQRES 17 A 242 GLY LEU LYS CYS LEU GLU HIS LEU PHE PHE PHE LYS LEU
SEQRES 18 A 242 ILE GLY ASP THR PRO ILE ASP THR PHE LEU MET GLU MET
SEQRES 19 A 242 LEU GLU ALA PRO HIS GLN MET THR
SEQRES 1 B 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS
SEQRES 2 B 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER
SEQRES 1 D 284 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY ARG ALA
SEQRES 2 D 284 GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR
SEQRES 3 D 284 ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS
SEQRES 4 D 284 ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SER
SEQRES 5 D 284 PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET GLY
SEQRES 6 D 284 GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN
SEQRES 7 D 284 GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY
SEQRES 8 D 284 CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR
SEQRES 9 D 284 GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP
SEQRES 10 D 284 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS
SEQRES 11 D 284 GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN LYS
SEQRES 12 D 284 ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR
SEQRES 13 D 284 ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP
SEQRES 14 D 284 PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN
SEQRES 15 D 284 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE
SEQRES 16 D 284 ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU
SEQRES 17 D 284 ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU
SEQRES 18 D 284 GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU
SEQRES 19 D 284 SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR
SEQRES 20 D 284 ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU
SEQRES 21 D 284 GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU HIS
SEQRES 22 D 284 PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR
SEQRES 1 E 23 ASN LEU VAL PRO ASP ALA ALA SER LYS HIS LYS GLN LEU
SEQRES 2 E 23 SER GLU LEU LEU ARG GLY GLY SER GLY SER
HET L79 A 463 28
HET 570 D 478 41
HETNAM L79 (S)-(2E)-3[4-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-2-
HETNAM 2 L79 NAPHTHALENYL)TETRAHYDRO-1-BENZOFURAN-2-YL]-2-PROPENOIC
HETNAM 3 L79 ACID
HETNAM 570 2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-
HETNAM 2 570 OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID
HETSYN 570 GI262570; FARGLITAZAR
FORMUL 5 L79 C25 H30 O3
FORMUL 6 570 C34 H30 N2 O5
FORMUL 7 HOH *205(H2 O)
HELIX 1 1 PRO A 231 ALA A 241 1 11
HELIX 2 2 ASP A 263 ARG A 285 1 23
HELIX 3 3 HIS A 288 LEU A 292 5 5
HELIX 4 4 PRO A 293 SER A 317 1 25
HELIX 5 5 ILE A 318 VAL A 320 5 3
HELIX 6 6 ARG A 334 HIS A 338 1 5
HELIX 7 7 VAL A 342 LEU A 353 1 12
HELIX 8 8 LEU A 353 MET A 360 1 8
HELIX 9 9 ASP A 363 PHE A 376 1 14
HELIX 10 10 ASN A 385 TYR A 408 1 24
HELIX 11 11 GLY A 413 LEU A 420 1 8
HELIX 12 12 ARG A 421 LEU A 441 1 21
HELIX 13 13 ASP A 448 LEU A 455 1 8
HELIX 14 14 HIS B 687 GLN B 695 1 9
HELIX 15 15 GLU D 207 PHE D 226 1 20
HELIX 16 16 THR D 229 GLY D 239 1 11
HELIX 17 17 ASP D 251 MET D 256 1 6
HELIX 18 18 GLU D 276 LYS D 301 1 26
HELIX 19 19 GLY D 305 LEU D 309 5 5
HELIX 20 20 ASP D 310 ALA D 331 1 22
HELIX 21 21 ARG D 350 SER D 355 1 6
HELIX 22 22 LEU D 356 PHE D 363 5 8
HELIX 23 23 MET D 364 ALA D 376 1 13
HELIX 24 24 ASP D 380 LEU D 393 1 14
HELIX 25 25 ASN D 402 HIS D 425 1 24
HELIX 26 26 GLN D 430 GLU D 460 1 31
HELIX 27 27 HIS D 466 LYS D 474 1 9
HELIX 28 28 LYS E 67 LEU E 73 1 7
SHEET 1 A 2 GLY A 323 LEU A 325 0
SHEET 2 A 2 HIS A 331 HIS A 333 -1 O VAL A 332 N ILE A 324
SHEET 1 B 4 PHE D 247 ILE D 249 0
SHEET 2 B 4 GLY D 346 THR D 349 1 O PHE D 347 N PHE D 247
SHEET 3 B 4 GLY D 338 ILE D 341 -1 N ILE D 341 O GLY D 346
SHEET 4 B 4 MET D 334 ASN D 335 -1 N ASN D 335 O GLY D 338
CISPEP 1 GLU A 243 PRO A 244 0 0.41
SITE 1 AC1 14 ILE A 268 ALA A 271 ALA A 272 GLN A 275
SITE 2 AC1 14 ASN A 306 LEU A 309 PHE A 313 ARG A 316
SITE 3 AC1 14 LEU A 326 ALA A 327 ILE A 345 PHE A 346
SITE 4 AC1 14 HIS A 435 LEU A 436
SITE 1 AC2 15 PHE D 282 GLY D 284 CYS D 285 GLN D 286
SITE 2 AC2 15 SER D 289 HIS D 323 TYR D 327 LEU D 330
SITE 3 AC2 15 ILE D 341 MET D 348 PHE D 363 HIS D 449
SITE 4 AC2 15 LEU D 465 LEU D 469 TYR D 473
CRYST1 49.690 54.580 211.700 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.020125 0.000000 0.000000 0.00000
SCALE2 0.000000 0.018322 0.000000 0.00000
SCALE3 0.000000 0.000000 0.004724 0.00000